Requadt Scott
- SEC CIK
- 0001664852
No open-market purchases or sales filed in the past year.
Current role at each company
- EPIX ESSA Pharma Inc.Directoras of Oct 15, 2025
- TRML Tourmaline Bio, Inc.Other: Former Chief Executive Officeras of Jul 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Requadt Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRML Tourmaline Bio, Inc.
Other: Former Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2022 (view filing) | Jul 29 | 4 days | Requadt ScottChief Executive Officer | PPurchase | +39.4K | $4.25 | +$167.4K | +8.4%508.7K after | |
| Jul 28, 2022 (view filing) | Jul 26-28 | 2 days | Requadt ScottChief Executive Officer | PPurchase | +8.62K | $4.24 | +$36.6K | +1.9%469.3K after | 2 lots |
| Jul 26, 2022 (view filing) | Jul 22 | 4 days | Requadt ScottChief Executive Officer | PPurchase | +9.44K | $3.75 | +$35.4K | +2.1%460.7K after |